This patent covers mesenchymal stem cells that are transfected with anything. Mesenchymal stem cells are very useful for clinical development since that do not need to be matched with HLA of the recipient in many situations, thus allowing for the use of an "off the shelf" product.
The advantage of transfecting mesenchymal stem cells with genes is that the mesenchymal stem cells can act as a delivery vector for the genes, to express them in a place that is therapeutically desirable.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.